N.Y. AG Spitzer Criticizes FDA "Silence" On Disclosing Rx Trial Data
This article was originally published in The Pink Sheet Daily
Executive Summary
In a speech at the National Press Club, Eliot Spitzer discusses his lawsuit against GlaxoSmithKline that resulted in a settlement in which the company will publicly disclose clinical trial data. He says FDA "has not said a word" that would require other drug manufacturers to do the same.